Carmat : Close to € 15m in net funds raised
>First target achieved - The capital increase launched several days ago raised a gross amount of € 16.5m which corresponds to a net amount of € 14.9m. The public, which represented 44% the operation, subscribed to the deal. As a reminder, the terms and conditions of the offer leading to the issuance of 3.6 million additional shares at a price of € 3.99, was rounded-out by close to 400k further shares following the partial exercising of the greenshoe option. ...Carmat is focused on the research and development of an innovative product in the medical sector, developing an orthotopic and biocompatible artificial heart which is completely implantable, as well as its electrical power supply system and remote diagnosis system. Co. is developing a long-term therapeutic solution for patients who suffer from advanced bi-ventricular heart failure and who are not eligible for cardiac transplantation and who have exhausted all drug possibilties. Co. is still in the phase of research and development and thus do not generate any revenues.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.